Poly(lactide-co-e-caprolactone) (PLCL) has been reported to be a good candidate for tissue engineering because of its good biocompatibility. Particularly, a braided PLCL scaffold (PLL/PCL ratio ¼ 85/15) has been recently designed and partially validated for ligament tissue engineering. In the present study, we assessed the in vivo biocompatibility of acellular and cellularised scaffolds in a rat model. We then determined its in vitro biocompatibility using stem cells issued from both bone marrow and Wharton Jelly. From a biological point of view, the scaffold was shown to be suitable for tissue engineering in all these cases. Secondly, while the initial mechanical properties of this scaffold have been previously reported to be adapted to load-bearing applications, we studied the evolution in time of the mechanical properties of PLCL fibres due to hydrolytic degradation. Results for isolated PLCL fibres were extrapolated to the fibrous scaffold using a previously developed numerical model. It was shown that no accumulation of plastic strain was to be expected for a load-bearing application such as anterior cruciate ligament tissue engineering. However, PLCL fibres exhibited a non-expected brittle behaviour after two months. This may involve a potential risk of premature failure of the scaffold, unless tissue growth compensates this change in mechanical properties. This combined study emphasises the need to characterise the properties of biomaterials in a pluridisciplinary approach, since biological and mechanical characterisations led in this case to different conclusions concerning the suitability of this scaffold for load-bearing applications.
Introduction
Among the variety of biodegradable polymers commonly used in tissue engineering (see for instance, recent reviews [1] [2] [3] [4] [5] [6] [7] [8] ), poly(lactide-co-e-caprolactone) (PLCL) has been reported to be a good candidate for tissue engineering. Indeed, the association of polylactic acid (PLLA) with poly(e-caprolactone) (PCL) into PLCL has been reported to compensate both the brittle behaviour of PLLA and the low stiffness of PCL 9, 10 as well as the local acidification due to the degradation of PLLA. 11 It also offers a slow degradation rate adapted to its use in tissue engineering, tailorable by changing the PCL/PLLA ratio. 12 A strong shape-memory effect has also been observed for PLCL, depending on PCL/ PLLA ratio. 13 The biocompatibility of PLCL in various shapes such as foams, 14 sheet-form scaffolds, 15 tubular porous scaffolds, [16] [17] [18] electrospun microfibres [19] [20] [21] [22] [23] [24] and tubular electrospun scaffolds 25 has been confirmed. PLCL in these various forms has been recently treated by plasma, 24, 26 loaded with heparin 27, 28 of growth factors, 29 or blended with gelatin 20, 30, 31 to improve cellular response. From these different assessments, it may be concluded that PLCL is a suitable material for various tissue engineering applications, especially when 'elasticity and degradability are required in the same product'. 10 Among the range of these various applications, PLCL has been used for ligament tissue engineering applications in our group [32] [33] [34] [35] or others. 36 Indeed, we have recently developed a braided PLCL scaffold for ligament tissue engineering with promising preliminary results concerning its mechanical, morphological and biological properties. [32] [33] [34] Particularly, this scaffold has been shown to be adapted to a computer-aided tissue engineering approach, 37 helping to predict and optimise both the scaffold properties and the cell's micro-environment that controls cellular activity. This geometry and the associated equipment developed for its processing could easily be applied to other clinical applications such as arteries, nerves or tendons. From a purely biological point of view, in vivo studies reporting the results of the implantation of such PLCL scaffolds are still lacking in the literature in order to assess their biological suitability, and in vitro studies for different culture conditions still need to be performed. The first objective of the present contribution is therefore to provide additional data concerning the biological suitability of PLCL-braided scaffolds based on results of in vivo and in vitro experiments. Particularly, these in vivo and in vitro studies respectively focus on (1) the effect of initial cellularisation of the scaffold on its capability to be colonised and vascularised in vivo and (2) the effect of cell source on the colonisation of the scaffold. Indeed, for this second point, current reported 34 studies on this PLCL scaffold have used stem cells issued from bone marrow, while other types of cells such as Wharton-jelly stem cells are gaining attention. 38 Despite these biological advantages of PLCL for tissue engineering applications, it has been reported that PLCL may be subject to ageing, and that post-crystallisation may have a drastic effect on its mechanical properties. 10, 39, 40 The estimation of scaffold degradation has often been limited to mass loss, 41 not necessarily linked to mechanical properties. When tested, the evolution in time of mechanical properties have been restricted to apparent properties (compressive modulus, ultimate strength, etc.) and limited to the elastic range. 42, 43 The effect of hydrolytic degradation on the mechanical behaviour of PLCL scaffolds has been insufficiently reported, while this constitutes a milestone in tissue engineering. 44 Indeed, this evolutive behaviour should be controlled since (1) the scaffold should fulfil the physiological function of the native tissue during the post-surgery phase, (2) accumulated plastic strain within the scaffold may lead to unsuited graft laxity for load-bearing applications and (3) the potential loss of mechanical properties in this period due to scaffold degradation should be compensated by tissue growth. The question of how these results can be confronted and used to assess the suitability of a scaffold for a given clinical application is then crucial. Indeed, the characterised initial mechanical properties may not be extrapolated to the post-implantation phase. Consequently, despite the encouraging reported studies concerning the biological suitability of PLCL for soft tissue engineering, data concerning the evolution of its mechanical properties during degradation are still lacking. This gap in knowledge may be partially explained by the extent of the campaign that should be carried on in order to perform the required mechanical experiments. A solution consists in chemically accelerating the hydrolysis, which has been recently applied to study the complex degradation mechanisms of a PCL scaffold for tendon tissue engineering. 44 Alternatively, we have recently developed 33 and validated 33, 35 computational tools capable of predicting the mechanical properties of braided scaffolds from the properties of isolated fibres. Such computational tools may drastically reduce the extent of the experimental campaign. These tools may incorporate recent models based on damage [45] [46] [47] [48] developed in order to take into account the variation of polymer mechanical properties during hydrolytic degradation. The second objective of the present contribution is therefore to study the change of mechanical properties of PLCL during degradation. This mechanistic point of view concerning the suitability of PLCL for soft tissue engineering applications brings information to be confronted to the reported biological results.
In the present paper, a braided scaffold made of PLCL in a PLA/PCL ratio of 85/15 is used. This particular polymer has been selected previously 32 based on a trade-off between deformability and stiffness. In a first section, the results of in vivo implantations of acellular and cellularised scaffolds after one and four weeks in a rat model are presented. This is completed with results of in vitro culture for two different types of stem cells. Conclusions are thus drawn concerning the biocompatibility of the PLCL scaffold from these combined in vivo and in vitro studies. In a second part, the effect of hydrolytic degradation on the mechanical properties of PLCL fibres is assessed and extrapolated to the braided scaffold using a computational model. Some new conclusions are then provided and discussed concerning both the biological and mechanical suitability of this polymer for soft tissue engineering applications.
Material and methods

Processing of PLCL fibres and scaffold preparation
The braided scaffold used in this study has already been described previously. 32 In vitro assessment of biocompatibility Mesenchymal stem cells isolation and expansion. The suitability of both bone marrow mesenchymal stem cells (BM-MSC) and Wharton Jelly mesenchymal stem cells (WJ-MSC) has been reported to be comparable for tissue engineering applications. 38 In this in vitro study, these two types of cells were therefore used and confronted. Human bone marrow and human umbilical cords were harvested and supplied by CHRU Hospital and Maternity Hospital (Nancy, France), respectively, with the informed consent of patients. For BM-MSC, 25 mL a-MEM (Lonza, BE12-169F) medium contained 10% FBS (Dominique Dutscher), 2 mM L-glutamine (Sigma, A-4034), 100 U/mL penicillin/streptomycin (Gibco, 15140-122), and 1 lg/mL amphoterin B (Gibco, 15290-026) was added to 20 mL of bone marrow and centrifuged at 300 Â g for 5 min. The supernatant was removed, cells were counted to be seeded on culture flask at the density of 50,000 cells/cm 2 , and then incubated in 37 C, 5% CO 2 , 90% humidity. The culture medium was changed twice a week. For WJ-MSC, human umbilical cord was first washed with 70% ethanol and cut into 3-4 cm in the HBSS buffer. The cord was opened and Wharton jelly was exposed, and the jelly was torn off from cordon and cut into fine pieces, and transferred to six-well plates. After seven days, the jelly was removed, and the culture medium was changed twice a week. All MSC used for assays are in passage 2(P2).
MSC metabolic activity and morphology on scaffold. The scaffolds were washed with phosphate-buffered solution (PBS), and then exposed to UV for 15 min each side. MSC with density of 300,000 cells (0.05 mL was distributed on each scaffold. MSC-scaffolds were then put in the incubator for 30 min, and supplied with 0.95 mL a-MEM complete medium with ascorbic acid (Sigma, A-4034). Cells were cultured on the scaffolds for two weeks. Alamar Blue (AB) tests were performed on D1, D3, D5 and D7. One millilitre of 10% AB work solution (Thermo scientific, 88952) was added to each scaffold and incubated for 3 h at 37 C; the solution was then aspired to test the optical density at 570 nm and 630 nm. The test was repeated three times (n=3).
The negative control was AB working solution without cells. MSC-scaffolds were first fixed with 1% paraformaldehyde for 10 min at room temperature and then washed three times with PBS. One millilitre of 0.5% triton-PBS was added to each for 20 min at room temperature. Scaffolds were washed three times with 1 mL PBS. Alexa 488 Phalloidin solution (250 mL) was added to each scaffold for 45 min. Scaffolds were then washed three times with PBS. DAPI (200 mL) (1/1500) was added to each scaffold for 15 min. Scaffolds were washed three times again with PBS and observed by florescence microscopy. Wavelengths used for florescence microscopy were, respectively, 456 nm for DAPI and 509 nm for Alea 488 Phalloidin.
Collagen synthesised on scaffold by immunofluorescence staining. Firstly, MSC-scaffolds were fixed with 1% paraformaldehyde for 10 min at room temperature, and washed three times with PBS. Then, 5% PBS-BSA blocking buffer was added to scaffolds for 1 h at room temperature, and then washed three times with PBS. A volume of 250 mL of the primer antibody collagen I rabbit (CALBIOCHEM, 234167), collagen III mouse (Sigma, C7805) at the dilution of 1/50, were added to scaffold for 1 h at room temperature, and then washed three times with PBS. The second antibody anti-rabbit IgG-Alexa488 (1/50) (Life technologies, A11008) and anti-mouse IgG-Alexa488 were added (250 mL) to scaffold for 45 min, washed three times with PBS. DAPI (250 mL) (1/1500) was added to each scaffold for 15 min and kept isolated from light. MSC-scaffolds were washed three times with PBS and imaged with fluorescence microscopy.
In vivo implantation of scaffolds
The in vivo behaviour of PLCL-braided scaffolds towards tissue colonisation and neo-vascularisation was assessed using a subcutaneous implantation site in an immunocompromised rodent model. The experiment also compared the regenerative performance of cell-seeded scaffolds to non-cellularised constructs and evaluated the impact of bone marrow mesenchymal stem cell on tissue remodelling. Scaffolds were sterilised by immersion in 70% ethanol for 30 min and subsequently UV-irradiated for 30 min and finally dried overnight in a biosafety cabinet as previously reported. 34 Human BM-MSC (Tulane University Center for Gene Therapy, USA) were expanded in DMEM supplemented with 16.5% calf foetal serum and 1% (v/v) antibiotics cocktail (Merckmillipore, 10,000 U/mL penicillin G, 10 mg/mL streptomycin, 25 lg/mL amphotericin B) as per the supplier protocol until 80% confluency. They were seeded into the braided scaffold (10 mm long) at P5 with a cell seeding density of 500,000 cells per scaffold. The seeding was performed in two steps to ensure homogeneous seeding: 250,000 cells in 50 mL of media were added onto the structure which was subsequently turned over to receive another 250,000 cells in 50 mL. The samples were placed in the incubator and 20 mL of warm media was added every 15 min for 2 h and subsequently every 30 min for another 2 h. At the end of the 4-h incubation period, the wells were filled with 1 mL of warm media supplemented with 100 mg/mL of ascorbate-2-phosphate to stimulate collagen production. The braided scaffolds were cultured under static conditions for four weeks with a three-weekly media change.
Animal ethics approval for the use of athymic nude rats in this experiment was granted by the Animal Ethics Committee of Griffith University. Six eightweek old male rats (Sprague-Dawley outbred rat model, Animal Resources Centre, Canning Vale, WA, Australia) were used. The animals were anaesthetised with isoflurane. Four small incisions were made 2 cm apart from the central line of the shaved dorsal area and subcutaneous pockets were using a pair of surgical scissors. In each animal, two scaffolds and two cellularised scaffolds were implanted. Each individual pocket held one scaffold and the incisions were closed with surgical sutures. The animals were sacrificed after one or four weeks post-implantation. The implants were retrieved and fixed in 4% paraformaldehyde in PBS at pH 7.4 for 24 h and thereafter immersed in PBS until further analysis. The samples were subsequently embedded in paraffin; sections near the central area of the specimens were used for haematoxylin and eosin (H&E) staining. The slides were scanned using the slide scanner Scanscope (Leica).
Mechanical tests on isolated PLCL fibres
Tensile tests were performed using a Zwick Roell 2.5 device (Zwick, Germany) equipped with a 2.5 kN cell force, at a tensile speed of 0.1 mm.s
À1
. Tests were performed in water with controlled temperature. Fibres of 60 cm in length were rolled up and then fixed around cylindrical parts (see Figure 1(a) ), in such a way that six fibres were tested in parallel. This setup was designed to (1) limit stress concentration at the level of fibre gripping, (2) increase the sensitivity of force measurement and (3) average the measurements of fibre properties by using several fibres. At each time step, four tensile tests were carried out, and the second Piola-Kirchhoff stress S 11 and the Green-Lagrange strain E 11 were computed from measured displacements and forces (where index 1 stands for the loading direction). This formulation is compatible with the large strain framework in which these tests were performed. The following loading cycle was prescribed (1) 1% strain then unloading, (2) 3% strain then unloading and (3) increasing strain up to failure (see Figure 1(b) ). The typical stress-strain response of PLCL polymer fibres at the initial time is represented on Figure 1 (c).
Numerical simulations for braided PLCL scaffold
The FE code dedicated to fibrous material used in this study has been previously described elsewhere, 49 as well as its application to the braided polymer scaffold. 33, 35 Briefly, in the simulations, each fibre was as a kinematically enriched finite strain beam model accounting for cross-sectional strains within a finite geometrical transformation framework. An original procedure was then used to detect the numerous contacts within the assembly of fibres, based on intermediate geometries used to create discrete contact elements and to determine the normal directions to the contact areas. The FE code predicted the initial geometry of the braid (and the associated initial stresses) from an arbitrary reference configuration in which fibres interpenetrated each other. 35 The non-interpenetrated configuration was then gradually computed from the knowledge of the braiding pattern within each scaffold layer. Average boundary conditions were defined on each scaffold layer using rigid bodies, thus enabling transverse rearrangement of individual fibres. Results were finally exported in terms of scaffold geometry at each loading step, strain tensors at many points generated on the surface of individual fibres and global forces and moments. Both the predicted response of the scaffold 33 and the predicted geometries of the collection of fibres 35 have been previously validated. In the FE code, the three-dimensional elasto-plastic response of isolated fibres was modelled using the relation
where S is the stress tensor, E is the strain tensor, C is the elastic stiffness tensor, Y is a yield function depending on the axial strain E 11 , E el is the elastic part of the deformation and e 0 is the yield strain. The yield function Y was expressed as follows
where a; b; c are three material constants. The continuity of S 11 and @S 11 =@E 11 at E 11 ¼ e 0 gives conditions on these constants, and consequently
The elasto-plastic response of fibres was thus fully described by three material parameters: the elastic modulus E, the yield strain e 0 and a hardening parameter c.
In the performed simulations, the case of anterior cruciate ligament (ACL) was considered as an application of the braided scaffold within a given physiological environment. From the computed initial geometry, a pretension phase was first simulated in order to condition the scaffold, as commonly done in clinics. 51 This phase consisted of a prescribed global strain of 4%, followed by a total unloading. Secondly, in order to evaluate the response of the braided scaffold to physiological loads, boundary conditions were defined such as they mimicked squats (i.e. one of the most common rehabilitation activities): this was done by prescribing a 3.6% axial strain. 52 Simulated force-strain curves for each time step were thus collected. The FE code was also used to determine the octahedral shear strain (OSS) at the surface of scaffold fibres. This stimulus was considered here to be the most influencing mechanical signal on cellular response as suggested in the literature. 53 OSS is defined as follows
where e I ; e II ; e III stand for the principal strains of the fibre scale Green-Lagrange strain tensor. The evolution of OSS during a squat exercise was investigated. OSS was set to zero at the end of the loading-unloading pretension phase, and then the distribution of OSS at the scaffold's surface at the end of the simulated exercise (strain ¼ 3.6%) was analysed.
Effect of hydrolytic degradation on mechanical properties
Tensile tests were performed on isolated PLCL fibres, at given times after the extrusion process. Prior to the extrusion, raw polymer was stored at À80 C. After the extrusion, polymer fibres were maintained in an incubator at 37 C within distilled water and tested in uniaxial tension at dedicated time points (days 0, 5, 8, 14, 19, 26, 32, 40, 49, 54, 60, 67, 75) . In recent studies, 45, 46, 48 it has been proposed that hydrolytic degradation may be modelled using a damage variable expressed as
where t is the time and l the strength decrease rate. Based on this work, we modelled the evolution of the Young's modulus of fibres using a damage parameter following an exponential law, such that the Young's modulus is null after full degradation
In this equation, E 0 is the initial Young's modulus and l E was fitted from experiments. Nonetheless, to the best of our knowledge, there was no fundamental basis enabling us to formulate the evolution of the yield strain e 0 and the hardening parameter c as a function of the degradation: therefore these laws were based on the results of our experiments, and formulated in a purely phenomenological way. In order to fit the Chaboche-type elasto-plastic model to experimental data, a least-square minimisation method was used based on the first part of the stress-strain curve, i.e. until the maximal stress is reached, ignoring the first unloading cycle.
Results
In vitro assessment of biocompatibility
WJ-MSC and BM-MSC were seeded on the scaffold, and the cell metabolic ability under static culture was detected by AB. For WJ-MSC and BM-MSC, cell metabolic ability both showed increased trend during one week ( Figure 2 ). For BM-MSC, the metabolic activity increased from 50% in D1 to 71.1% in D7, while for WJ-MSC, it increased from 37% in D1 to 63.7% in D7. On day 14, cells were fixed and cell skeleton (green) and cell nuclei (blue) were stained to show the cell morphology and cell location on the scaffold. Cells proliferated well on PLCL scaffold, and bridges were formed between fibres, after one week.
The expression of collagen secreted by BM-MSC and WJ-MSC on PLCL scaffolds was detected by immunofluorescence staining. As shown in Figure 3 , collagen I and III were synthesized by BM-MSC and WJ-MSC on the scaffolds. Collagen (greed dot on Figure 3 ) was found to cover the fibres and form bridges between them. No significant differences were observed between BM-MSC and WJ-MSC.
In vivo implantation of scaffolds
The healing course of the animals was uneventful, and Figure 4 displays the representative gross morphology of the retrieved samples at one and four weeks. After one week post-implantation, the braided scaffold integrated well with the surrounding tissue, a fibrous capsule was formed around the implant and the presence of numerous blood vessels in the direct vicinity of the scaffolds (square arrow head Figure 4 (a) and (b)) was noted regardless of the group. A red colour was also observed in the core of the braided scaffold suggesting high vascularisation. Similar observations were made four weeks post-implantation, with the presence of blood vessels in the direct proximity of the scaffold (square arrow head). The H&E staining revealed that the scaffolds were fully colonised by the host tissue as early as one week post-implantation as shown in Figure 4 (a) and (b) regardless of the presence of MSC. In both cases, a dense collagenic network had formed within the pore of the braided structure. A mild inflammatory response was also observed on the periphery of the filaments (indicated by the *, note that the polymer was in some location dissolved during the histological sample processing hence leaving a void) with polynucleated cells (round arrow head) surrounding the polymeric material. The tissue in the central portion of the braided scaffolds was particularly well vascularised with the presence of numerous microvessels but also larger blood vessels (black arrows) for both acellular and cellularised constructs.
Similar features were observed at four weeks postimplantation demonstrating that the scaffold was capable of maintaining high degree of tissue colonisation (Figure 4(c) and (d) ) with the development of a significant vascular network, hence avoiding a necrotic core. Noteworthy, the scaffold did not show any sign of an acute degradation using this subcutaneous model and the inflammatory response while still present did not increase notably.
Effect of hydrolytic degradation on mechanical properties
Typical experimental results at days 0, 32 and 75 are reported in Figure 5 . The decrease in Young's modulus was clearly observed during the degradation process, as reported in previous studies. 48 However, less intuitive behaviour was observed concerning the inelastic part of the response. Firstly, the maximal admissible stress gradually increased in the first month, and then decreased. Secondly, the strain to rupture gradually increased in the first month until it reached high values (more than 50%), and then drastically decreased from the sixth week. Fibres were rather brittle at day 75, with a strain to rupture around 2%.
The Chaboche-type elasto-plastic law was fitted to stress-strain curves for each tensile test (n ¼ 4), for time steps equal to 0, 5, 8, 14, 19, 26, 32, 40, 49, 54, 60 , 67, 75 days. The results in terms of the evolution of material parameters are illustrated in Figure 6 . These evolutions were simplified by phenomenological models in order to represent the global tendency of the evolution of fibres properties during degradation. The Young's modulus was represented using a damage variable as introduced in equation (5), and the fitting algorithm resulted in the value l E ¼ 0:0024. Given the experimental results for the hardening parameter c, a similar law was used introducing a new decrease rate l c and a constant value c 1 such that the hardening parameter does not tend to zero. Fitted parameters were l c ¼ 0:6 and c 1 ¼ 100. Yield strain showed a non-monotonic evolution characterised by a slight initial increase followed by a decrease, such as it finally tended to its initial value. In the simulations, a constant value of e 0 ¼ 0:1 was selected because of the lack of physical basis describing such an evolution. No values of hardening parameter or yield strain were obtained from day 60, as long as the fibres were brittle and failed before entering the plastic region.
The evolution of force-strain response of the braided scaffold due to polymer degradation is represented in Figure 7 . A decrease in elastic properties of the scaffold due to the degradation of individual fibres was clearly observed. No accumulation of plastic strain during the degradation was observed even after six months.
From these data, we estimated the ideal contribution of tissue growth to the evolution of construct mechanical properties, as represented in Figure 8 .
The distribution of OSS before and after squat exercise at each time step is represented in Figure 9 . At day 60, around 9% of the OSS at the scaffold surface was above 2%, which corresponds to the strain at failure experimentally observed for individual fibres at this time point. These maximum strains were observed in the central layers of the scaffold, since the fibre recruitment during loading occurred from the core to the periphery of the scaffold.
Discussion
While the issue of choosing the adequate material for a given tissue engineering application is still a milestone, we proposed in the present contribution to provide new data concerning the mechanical and biological properties of a PLCL-braided scaffold. A recent questionnaire has indeed shown that surgeons would consider using tissue-engineered ligament 'provided that it showed biological and mechanical success'. 54 Firstly, we reported the results of in vivo subcutaneous implantations of PLCL scaffolds using a rat model. From histological observations, the PLCL-braided scaffold was shown to be suitable for tissue engineering since it promoted tissue colonisation, even when initially non-cellularised, as well as external vascularisation. No particular inflammatory response was observed, and no degradation was detected four weeks after implantation. No difference was observed between acellular or cellularised scaffold, indicating a high capability of maintaining high degree of tissue colonisation and vascularisation for both groups. We also reported additional data concerning the in vitro biocompatibility of PLCL scaffolds for two different types of cells that constitute privileged cell sources for soft tissue engineering. Satisfying results were obtained concerning the cell proliferation and collagen secretion for stem cells issued both bone marrow and Wharton jelly, indicating that BM-MSC-scaffold and WJ-MSC-scaffold both have a good potential to be used as biomaterial for tissue regeneration. No significant difference between these two types of cells were observed, while different responses of BM-MSC and WJ-MSC have been reported in the literature. 38 The results indicated that WJ-MSC showed a high capacity to colonise the PLCL scaffold. As a result, WJ-MSC may constitute a promising alternative to BM-MSC due to their accessibility and expansion potential. 38 From these in vivo and in vitro studies, PLCLbraided scaffolds appeared to be a suitable choice for various tissue engineering applications due to their excellent biocompatibility.
In a second part of this work, we reported original data concerning the effect of degradation on the elastoplastic behaviour of PLCL fibres. Material parameters of a Chaboche-type elasto-plastic law were fitted from experimental data over more than two months. Irregular curves and substantial standard deviations were, however, obtained and may be attributed to irregularities in fibre diameter (due to the custom Figure 8 . Ideal contribution of tissue growth to the evolution of the maximal stress (left) and the force reached for a 3.6% strain of the scaffold (right). The ideal contribution of tissue growth is represented with a blue dashed line. extrusion process), and to the non-unicity of the fitted elasto-plastic law. These data were then extrapolated using a computational approach in order to assess the mechanical properties of the braided scaffold, and therefore its suitability for load-bearing tissue engineering applications. A typical example of ACL tissue engineering was taken as one of those load-bearing applications. Interestingly, the elasto-plastic response of fibres changed in a non-intuitive way due to degradation, showing an increase in strain at failure and maximal stress followed by a sudden decrease of these parameters. This evolution differed from observations recently reported on a jet-printed PCL scaffold for tendon repair. 44 It therefore indicates that different materials and structures may have drastically different degradation mechanisms and profiles, and it emphasises the need to systematically study this evolution before drawing conclusions about the suitability of a scaffold for a given application. A first element of explanation of such an evolution of material properties could be the shortening of polymeric chains due to hydrolysis, which then come small enough to act as a plastifier, hence increasing the stain at failure. On the other hand, as the chain was shortened during hydrolysis, the re-crystallisation could explain the observed increase in the stress at yield. To validate this assumption, further physico-chemical experiments may be conducted in the future on this particular polymer during hydrolytic degradation. It is worthy to note that the evolution of individual fibres mechanical properties was characterised based uniquely on hydrolytic degradation within distilled water at 37 C. However, it has been previously reported that enzyme degradation occurring in vivo may catalyse the polymer degradation, and that in vivo and in vitro degradation may be heterogeneous. 55, 56 In order to overcome this limitation, a large experimental study aiming at characterising the properties of fibres (and/or braided scaffolds) after in vivo implantation could be performed in the future. Alternatively, the degradation of fibres could have been performed in a different solution, containing additives, enzymes or drugs.
The FE simulations then permitted to state that this degradation did not induce any accumulation of plastic strain within the scaffold for the physiological conditions of ACL. Due to structural effects, the scaffold did not enter into the plastic zone for the simulated physiological loading (3.6% of global strain), even if the fibres would individually deform plastically for such a strain. After six months, the loading capacity of the scaffold decreased to around 40%. This decrease should then ideally be compensated by tissue growth and the creation of a collagen network. Thanks to these simulation, the ideal participation of tissue growth to the maintain of suited mechanical properties was estimated. However, and more importantly, these results showed that the fibres exhibited a brittle behaviour after two months of in vitro degradation. The analysis of simulation results permitted to affirm that the central fibres of the scaffold may fail for postimplantation time above 60 days, since the local strains were superior to the observed strain at failure. Alternatively, it may be concluded that tissue growth should compensate this brittle behaviour within 60 days after implantation.
Several original conclusions may be drawn from the present study, answering gaps of knowledge present in the current state of art. Firstly, from a purely biological point of view, we confirmed that PLCL was a suitable choice for various tissue engineering applications, seeded or non-seeded with BM-MSC and WJ-MSC. Secondly, we emphasised that the mechanical properties of the selected material showed a non-intuitive evolution due to degradation. As a consequence, the conclusions that were made initially concerning the suitability of the PLCL scaffold used in this study for load-bearing applications such as ACL tissue engineering 33 may not be valid anymore if we consider this evolution in time. In fact, we showed that the risk of brittle failure of PLCL scaffold was high after two months of degradation due to the change it strain at failure. It contradicts premature conclusions that have been drawn in the literature, including in our previous studies, 33, 35 concerning the adapted mechanical response of this scaffold. Consequently, it appears then crucial from these results that a sufficient tissue growth compensate this evolution of mechanical properties within a period of two months, which should be assessed in the future during long-term culture within the dedicated bioreactor developed in our team. 34 This study emphasises the need to characterise the properties of biomaterials in a pluridisciplinary approach and to consider the evolution of these mechanical properties prior to the assessment of their suitability for a given application. It is worthy to emphasise that this study was conducted for a specific type of PLCL, with a PLLA/PCL ratio of 85/15. Different results may be obtained for different ratios and therefore one must not conclude too rapidly that PLCL is to be excluded for any soft tissue engineering application in the future. Alternatively, work may be performed in the future in order to optimise the PLCL chemical composition in such a way that the observed brittle behaviour is reduced.
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